University of Minnesota Cancer Care thoracic surgeon Rafael Andrade, MD, will present 2 case studies at upcoming conferences on thoracic surgery. Both review the laparoscopic transdiaphragmatic surgical approach, comparing its safety and outcomes to those of traditional surgeries. This less-invasive option was pioneered at the University of Minnesota. Andrade will present “Laparoscopic TransDiaphragmatic Thymectomy” at the American Association for Thoracic Surgeons Annual Meeting 2015, held April 25-29 in Seattle. The second, “Laparoscopic Trans-Diaphragmatic Lung Wedge Resection,” will be delivered at the 23rd European Conference on General Thoracic Surgery in Lisbon, Portugal.
The University of Minnesota Cancer Care lung-screening program has been designated a Screening Center of Excellence, the only one in Minnesota to be so named. Granted by the Lung Cancer Alliance, the designation identifies centers that comply with best practices for screening and diagnosis, provide timely reporting, and offer a multidisciplinary team and comprehensive, coordinated care. The lung-screening location at University of Minnesota Medical Center also provides oversight for the screening program at Fairview Maple Grove Medical Center. Lung-screening appointments can be scheduled at 855-486-7226. Screening is recommended for smokers and ex-smokers between the ages of 55 and 79 who smoked at least one pack of cigarettes a day for 30 or more years or who have a 30-pack-year history. Ex-smokers are considered to be those who have quit smoking in the past 15 years.
Manish Patel, DO, has been named a Research Fellow by the Minnesota-based A Breath of Hope Lung Foundation. The award recognizes Patel’s research into oncolytic virotherapy for metastatic non-small cell lung cancer. In laboratory experiments in cultures and in mice, Patel found vesicular stomatitis virus, which was further engineered to produce interferon-β (VSV-IFNβ), to be highly effective against non-small cell lung cancer. He proposes to use blood outgrowth endothelial cells to carry and deliver VSV-IFNβ directly to cancer tumors.
The two-year $150,000 award is intended to support and retain talented young investigators in the field of lung cancer research.
Research comparing outcomes of thoracic cancer patients indicates that minimally invasive techniques are associated with improvements in morbidity rates, lengths of hospital stay, and postsurgical pain.Continue reading
A 25-year-old, active male patient with a large and fast-growing mediastinal germ cell tumor was successfully treated with chemotherapy and an aggressive, complete tumor resection.Continue reading